ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,750 | +114.4% | 183 | +108.0% | 0.00% | – |
Q2 2023 | $1,749 | +16.1% | 88 | 0.0% | 0.00% | – |
Q1 2023 | $1,507 | -12.5% | 88 | 0.0% | 0.00% | – |
Q4 2022 | $1,722 | +72.2% | 88 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 88 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -90.0% | 88 | -62.7% | 0.00% | -100.0% |
Q1 2021 | $10,000 | -88.6% | 236 | -85.2% | 0.00% | -90.9% |
Q4 2020 | $88,000 | +125.6% | 1,600 | -5.9% | 0.02% | +100.0% |
Q3 2020 | $39,000 | +85.7% | 1,700 | +13.3% | 0.01% | +37.5% |
Q1 2020 | $21,000 | -38.2% | 1,500 | 0.0% | 0.01% | -33.3% |
Q4 2019 | $34,000 | -2.9% | 1,500 | -50.0% | 0.01% | -7.7% |
Q3 2019 | $35,000 | +133.3% | 3,000 | +200.0% | 0.01% | +116.7% |
Q2 2019 | $15,000 | +114.3% | 1,000 | +100.0% | 0.01% | +100.0% |
Q4 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |